Share Email Print
cover

Proceedings Paper

Improvement of tumor response to photodynamic therapy by manipulation of tumor oxygenation in an in-vivo model system
Author(s): Qun Chen; Zheng Huang; Hua Chen; Howard Shapiro; Jill Beckers; Fred W. Hetzel
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Photodynamic therapy (PDT) requires molecular oxygen during light irradiation in order to generate reactive oxygen species. Tumor hypoxia, either pre-existing or induced by PDT, can severely hamper the effectiveness of PDT treatment. Lowering the light irradiation dose rate or fractionating a light dose may improve cell kill of PDT induced hypoxic cells, but will have no effect on pre-existing hypoxic cells. In this study, hyper-oxygenation technique was used during PDT to overcome hypoxia. C3H mice with transplanted mammary carcinoma tumors were injected with 12.5 mg/kg Photofrmn and irradiated with 630 nm laser light 24 hours later. Tumor oxygenation was manipulated by subjecting the animals to 3 alp hyperbaric oxygen or normobanc oxygen during PDT light irradiation. The results show a significant improvement in tumor response when PDT was delivered during hyper-oxygenation. With hyper-oxygenation, up to 80% of treated tumors showed no re-growth after 60 days. In comparison, only 20% of tumors treated while animals breathed room air did not re-grow. To explore the effect of hyperoxygenation on tumor oxygenation, tumor PO2 was measured with microelectrodes positioned in pre-existing hypoxic regions before and during the PDT. The results show that hyperoxygenation may oxygenate pre-existing hypoxic cells and compensate for oxygen depletion induced by PDT light irradiation. In conclusion, hyper-oxygenation may provide effective ways to improve PDT treatment efficiency by oxygenating both pre-existing and treatment induced cell hypoxia.

Paper Details

Date Published: 12 September 2002
PDF: 10 pages
Proc. SPIE 4916, Optics in Health Care and Biomedical Optics: Diagnostics and Treatment, (12 September 2002); doi: 10.1117/12.482964
Show Author Affiliations
Qun Chen, HealthONE Alliance (United States)
Zheng Huang, HealthONE Alliance (United States)
Hua Chen, HealthONE Alliance (United States)
Howard Shapiro, HealthONE Alliance (United States)
Jill Beckers, HealthONE Alliance (United States)
Fred W. Hetzel, HealthONE Alliance (United States)


Published in SPIE Proceedings Vol. 4916:
Optics in Health Care and Biomedical Optics: Diagnostics and Treatment
Britton Chance; Mingzhe Chen; Gilwon Yoon, Editor(s)

© SPIE. Terms of Use
Back to Top